|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.90 BDT | +1.29% |
|
+5.07% | +5.07% |
| Market Cap | 25.39B 207M 180M 166M 156M 292M 19.48B 294M 1.98B 767M 9.6B 776M 759M 33.27B | P/E 2024 |
68.2x | P/E 2025 | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.35B 288M 251M 231M 217M 407M 27.13B 410M 2.75B 1.07B 13.37B 1.08B 1.06B 46.33B | EV / Sales 2024 |
4.25x | EV / Sales 2025 | 2.74x |
| Free-Float |
36.94% | Yield 2024 |
1.3% | Yield 2025 | 1.98% |
| 1 day | +1.29% | ||
| 1 week | +5.07% | ||
| Current month | +8.06% | ||
| 1 month | +8.49% | ||
| 3 months | +7.85% | ||
| 6 months | +7.64% | ||
| Current year | +5.07% |
| 1 week | 105.2 |  | 115 |
| 1 month | 100.2 | | 115 |
| Current year | 96 | | 115 |
| 1 year | 96 | | 147.5 |
| 3 years | 92.4 | | 288.9 |
| 5 years | 92.4 | | 393 |
| 10 years | 16 | | 393 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ulfat Karim
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | - | |
| Director/Board Member | 42 | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +5.07% | +5.67% | -55.14% | 207M | |
| +32.62% | -5.37% | +39.94% | +145.38% | 980B | |
| -3.20% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -2.10% | +0.25% | +25.86% | +16.53% | 317B | |
| +0.94% | -1.29% | +25.93% | +14.10% | 270B | |
| +0.88% | -2.49% | +25.03% | +31.03% | 269B | |
| +4.86% | +2.25% | -39.86% | -45.75% | 191B | |
| -1.90% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| Average | -0.25% | -2.66% | +18.20% | +30.53% | 329.42B | |
| Weighted average by Cap. | -0.92% | -3.38% | +28.36% | +64.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.7B 87.13M 75.92M 69.98M 65.83M 123M 8.21B 124M 833M 323M 4.05B 327M 320M 14.03B | 12.54B 102M 88.98M 82.02M 77.15M 144M 9.62B 145M 976M 379M 4.74B 383M 375M 16.44B |
| Net income | 521M 4.24M 3.7M 3.41M 3.2M 6M 400M 6.04M 40.54M 15.74M 197M 15.92M 15.58M 683M | 947M 7.71M 6.71M 6.19M 5.82M 10.89M 726M 10.97M 73.64M 28.6M 358M 28.93M 28.31M 1.24B |
| Net Debt | 10B 81.39M 70.92M 65.38M 61.49M 115M 7.67B 116M 778M 302M 3.78B 306M 299M 13.1B | 9.96B 81.12M 70.68M 65.16M 61.29M 115M 7.65B 115M 775M 301M 3.77B 304M 298M 13.06B |
Employees
4,771
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 109.90 BDT | +1.29% | 407,949 |
| 17/06/26 | 108.50 BDT | -0.18% | 387,118 |
| 16/06/26 | 108.70 BDT | -2.16% | 701,976 |
| 15/06/26 | 111.10 BDT | -1.42% | 858,592 |
| 14/06/26 | 112.70 BDT | +7.74% | 1,749,001 |
- Stock Market
- Stocks
- BEACONPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
